CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0078

YK-11 Raw

Filed under Raw Materials. The bureau holds 115 laboratory returns for this compound from 41 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

41 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Hubei JianxiangCASE #VI-2026-0048 A 4 10.0 10.0 10.0 9 Mar 2026 4 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 3 10.0 10.0 10.0 20 Mar 2026 10 Jul 2026
JEEP PeptidesCASE #VI-2026-0457 A 3 10.0 10.0 10.0 3 Feb 2026 22 Apr 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 10.0 10.0 10.0 14 Mar 2026 6 May 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 3 10.0 9.9 10.0 14 Apr 2026 13 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 3 10.0 9.9 10.0 14 Feb 2026 27 Jun 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 9.9 10.0 5 Apr 2026 21 Jul 2026
AsymchemCASE #VI-2026-0091 A 3 10.0 9.9 10.0 20 May 2026 5 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 9.9 10.0 22 Jun 2026 18 Aug 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 10.0 10.0 10.0 2 May 2026 8 Jul 2026
Trusted PeptideCASE #VI-2026-0499 X 1 10.0 10.0 10.0 13 Jun 2025 13 Jun 2025
HomopeptideCASE #VI-2026-0760 A 6 9.9 9.9 10.0 23 May 2026 23 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 6 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 4 9.9 9.9 10.0 20 Dec 2025 6 Jul 2026
BachemCASE #VI-2026-0314 A 4 9.9 9.9 10.0 16 Mar 2026 1 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 4 9.9 9.9 9.9 5 Nov 2025 23 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 9.9 9.9 10.0 18 May 2026 3 Aug 2026
Kerui PeptidesCASE #VI-2026-0626 A 3 9.9 9.9 10.0 21 Jan 2026 1 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 9.9 9.9 10.0 26 Mar 2026 27 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 3 9.9 9.9 10.0 2 Apr 2026 28 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 9.9 9.9 10.0 27 Dec 2025 8 Aug 2026
Sangon BioCASE #VI-2026-0671 A 2 9.9 9.9 9.9 26 Jun 2026 2 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 19 Mar 2026 8 May 2026
SinoPepCASE #VI-2026-0387 A 2 9.9 9.9 10.0 25 May 2026 18 Jun 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 6 9.0 8.1 9.7 23 May 2026 23 May 2026
EHZ PeptidesCASE #VI-2026-0296 X 1 9.0 9.0 9.0 2 Jul 2025 2 Jul 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 6 8.4 7.7 9.4 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 8.4 7.7 9.3 25 May 2026 25 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 3 8.4 7.7 9.5 24 May 2026 24 May 2026
Huaian Hanyou PeptideCASE #VI-2026-0297 X 1 8.2 8.2 8.2 16 Mar 2025 16 Mar 2025
Glbiochem (Shanghai)CASE #VI-2026-0704 A 2 8.1 7.1 9.2 24 May 2026 24 May 2026
Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 X 1 7.1 7.1 7.1 11 Jun 2025 11 Jun 2025
Mix PeptidesCASE #VI-2026-0699 X 2 6.8 5.8 7.9 11 Jun 2025 19 Jan 2026
HazelCASE #VI-2026-0392 X 1 6.5 6.5 6.5 14 Jan 2025 14 Jan 2025
Qingdao VitaConin International TradingCASE #VI-2026-0504 X 1 5.9 5.9 5.9 6 May 2025 6 May 2025
Royal PeptidesCASE #VI-2026-0264 X 2 5.8 5.4 6.2 2 Jul 2025 24 May 2026
Xingtai Lesda TechnologyCASE #VI-2026-0381 X 1 5.7 5.7 5.7 13 Jun 2025 13 Jun 2025
Richards Biotech Simply RichardsCASE #VI-2026-0307 X 1 5.2 5.2 5.2 24 Apr 2025 24 Apr 2025
Loti LabsCASE #VI-2026-0171 X 3 4.1 3.0 4.9 24 Apr 2025 17 May 2026
Swiss ChemsCASE #VI-2026-0030 X 1 3.2 3.2 3.2 3 Jul 2025 3 Jul 2025
PRIVATECASE #VI-2026-0635 X 1 0.0 0.0 0.0 13 Feb 2025 13 Feb 2025

Open any subject to view the batch-level evidence for YK-11 Raw alone.